---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-21-237704"
form_type: "8-K"
ticker: "RMD"
cik: "0000943819"
company_name: "RESMED INC"
filed_at: "2021-08-05T23:59:59+00:00"
generated_at: "2026-06-29T22:14:39.939698+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# ResMed Q4 FY2021 revenue up 14% to $876.1M, dividend increased 8% to $0.42

## Summary
- Q4 revenue $876.1M (+14% YoY); non-GAAP operating profit up 7%; diluted non-GAAP EPS $1.35.
- Full-year FY2021 revenue $3.2B (+8% YoY); non-GAAP operating profit up 12%; non-GAAP EPS $5.33 (+12%).
- Quarterly dividend raised 8% to $0.42/share; payable Sep 23, record Aug 19.
- Company cites ongoing recovery in sleep apnea patient flow and tailwind from competitor quality issue.
- GAAP net income down 24% for FY due to prior-year gain; non-GAAP net income up 13%.

## SEC filing metadata
- accession: 0001193125-21-237704
- form_type: 8-K
- ticker: RMD
- cik: 0000943819
- company_name: RESMED INC
- filed_at: 2021-08-05T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 2.02, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/943819/000119312521237704/0001193125-21-237704-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/943819/000119312521237704/d189129d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-21-237704
- JSON: https://secwatch.observer/filing/0001193125-21-237704.json
- Plain text: https://secwatch.observer/filing/0001193125-21-237704.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.